FDA Inspection 584934 — CBI Laboratories, Inc.

CBI Laboratories, Inc. — FEI 1629952

The FDA completed an inspection of CBI Laboratories, Inc. on May 1, 2009 in Fort Worth, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 8 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 1, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fort Worth, TX (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
192621 CFR 211.166(b)Adequate number of batches on stability
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
431521 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs
435721 CFR 211.166(a)Results not used for expiration dates, storage cond.
436821 CFR 211.188(b)(12)Investigations made into any unexplained discrepancy
457621 CFR 211.192No written record of investigation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.